The organic acids test (OAT) measures dozens of small organic molecules in urine that reveal how efficiently cells convert food to energy, whether neurotransmitter synthesis is working, and whether specific vitamin cofactors are adequate.
What she actually had — revealed by an organic acids test ordered by a functional medicine physician on her tenth appointment — was a textbook case of mitochondrial dysfunction with depleted riboflavin and B12, impaired tryptophan metabolism producing elevated quinolinic acid, gut dysbiosis markers showing Candida overgrowth, and functional vitamin D insufficiency affecting enzyme activity. The test cost less than a single specialist consultation. It had been available for decades. Nobody had ordered it.
The organic acids test (OAT) is one of the most information-dense, mechanistically rich diagnostic tools in functional and integrative medicine — and one of the least understood by both conventional practitioners and patients. It measures dozens of small organic molecules in urine that are intermediate or end products of metabolic pathways.
The pattern of these molecules provides a window into how efficiently cells are converting food to energy, whether neurotransmitter synthesis is working, what the gut microbiome is producing, and whether specific vitamin cofactors are adequate for enzyme function.
Understanding what’s actually being looked at in an OAT report requires understanding the metabolic pathways those acids reflect. This walks through the major categories systematically: the biochemistry, what abnormal patterns mean clinically, and how the findings translate to actionable interventions. Not a substitute for clinical interpretation. Background knowledge for intelligent collaboration with whoever is interpreting the results.
What Is Organic Acids Testing and Why Urine?
Organic acids are carbon-containing compounds with at least one carboxyl group (-COOH). Produced throughout normal metabolism — as intermediates in the Krebs cycle, byproducts of amino acid catabolism, products of fatty acid oxidation, bacterial fermentation products from the gut, and compounds reflecting cofactor availability and enzyme activity — they accumulate in blood and get filtered and concentrated in urine, making urine an ideal matrix for detection and quantification.
The technology underlying OAT is gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods separate hundreds of compounds by their physical and chemical properties and identify them by their characteristic molecular fragmentation patterns and mass-to-charge ratios. Modern OAT panels detect 70 to 100 or more distinct organic acids, each reflecting a specific aspect of cellular metabolism.
The key advantage of OAT over direct nutrient testing (simply measuring blood levels of vitamins and minerals) is that it measures functional sufficiency rather than just serum concentration. Many cofactor deficiencies are “functional” — the serum level looks normal, but the specific enzymatic reactions requiring that cofactor aren’t working normally. That happens because serum levels reflect current intake and storage, while organic acid patterns reflect what’s actually happening inside cells where the enzymes operate.
A person can have a serum B6 level of 30 nmol/L (technically normal) but have genuinely impaired B6-dependent enzyme function if, say, their methylation cycle is consuming B6 faster than it’s being supplied.
Different laboratories offer different OAT panels: Great Plains Laboratory’s OAT is one of the most widely used in functional medicine practice; Genova Diagnostics offers the NutrEval and Metabolomix+ panels; Mosaic Diagnostics (formerly Great Plains) and Vibrant Wellness also offer variations. The specific markers, reference ranges, and groupings vary between laboratories, which means results from different companies can’t be directly compared. The underlying metabolic biochemistry is the same. The specific tests and cutoffs differ.
Krebs Cycle Acids: The Engine Room of Cellular Energy
The citric acid (Krebs) cycle is the central hub of aerobic energy metabolism. Eight sequential enzyme-catalyzed reactions convert acetyl-CoA — derived from carbohydrate, fat, and protein metabolism — into CO2, NADH, FADH2, and GTP, feeding electrons into the mitochondrial electron transport chain that produces ATP. Disruptions to this cycle show up in the organic acids profile as elevation of intermediates upstream of blocked steps and depletion of intermediates downstream.
Citric acid (citrate) is the first Krebs cycle intermediate, produced when acetyl-CoA condenses with oxaloacetate. Elevated citrate can indicate the cycle is slowed at a downstream step, letting citrate accumulate, or it may reflect increased flux through citrate as a precursor for lipid synthesis (citrate is exported from mitochondria for fatty acid synthesis). Low citrate may indicate insufficient oxaloacetate, which suggests depletion of anaplerotic substrates — amino acids like glutamine and aspartate that replenish cycle intermediates.
Succinic acid is the Krebs cycle intermediate whose elevation most strongly suggests mitochondrial Complex II dysfunction or downstream blockade. Complex II (succinate dehydrogenase) converts succinate to fumarate.
Elevated succinate with reduced fumarate and malate suggests impaired Complex II activity, which may result from genetic variants in succinate dehydrogenase subunit genes (associated with hereditary paraganglioma and pheochromocytoma at the extreme end, but also contributing to mitochondrial function impairment in less extreme variants), from nutrient cofactor insufficiency (riboflavin is required for Complex II via FAD), or from oxidative damage to the enzyme complex.
Fumaric acid and malic acid elevations can indicate impaired malate dehydrogenase activity or simply reflect increased flux through this part of the cycle. In the context of the aspartate-malate shuttle — the mechanism by which NADH from the cytoplasm enters the mitochondria — elevated fumarate may indicate shuttle impairment reducing mitochondrial reducing equivalents available for the electron transport chain.
This shuttle requires aspartate and malate transporters across the inner mitochondrial membrane, transporters that can be disrupted by oxidative damage to the membrane.
Alpha-ketoglutaric acid (alpha-KG) is a critical intersection point: a Krebs cycle intermediate, but also the carbon skeleton produced by transamination of glutamate, connecting the cycle to amino acid metabolism. Elevated alpha-KG suggests impaired isocitrate dehydrogenase or alpha-KG dehydrogenase activity. Alpha-KG dehydrogenase requires thiamine (B1), lipoic acid, CoA, riboflavin (B2), and niacin (B3) as cofactors — its activity is a sensitive indicator of multiple B vitamin adequacies simultaneously.
When this enzyme is impaired, the Krebs cycle bottlenecks and energy production suffers.
Pyruvic acid (pyruvate) elevation is among the most clinically important OAT findings. Pyruvate is the entry point for glucose into the Krebs cycle via the pyruvate dehydrogenase complex (PDC). Elevated pyruvate means PDC isn’t functioning adequately — pyruvate isn’t being converted to acetyl-CoA at the rate it’s being produced.
This creates a metabolic traffic jam: glucose gets broken down through glycolysis but can’t efficiently enter the Krebs cycle, forcing the cell toward lactate production (anaerobic glycolysis) as the only available route. PDC requires thiamine, lipoic acid, CoA, riboflavin, and niacin. Elevated pyruvate therefore points directly toward thiamine deficiency or functional insufficiency as a first priority to investigate.
Fatty Acid Oxidation Markers
Fatty acid oxidation (beta-oxidation) is the primary fuel source for the body at rest and during moderate activity. The OAT provides several markers that reflect the efficiency of this pathway and whether specific cofactors required for fatty acid transport and metabolism are adequate.
Suberic, sebacic, adipic, and other medium- and long-chain dicarboxylic acids accumulate when fatty acid beta-oxidation is impaired. These dicarboxylic acids form when fatty acids get metabolized via omega-oxidation (an alternate cytochrome P450-mediated pathway in the endoplasmic reticulum) rather than the normal beta-oxidation pathway in mitochondria.
Elevated dicarboxylic acids therefore indicate fatty acids are getting redirected away from efficient mitochondrial beta-oxidation toward a less efficient alternative route — typically because carnitine transport into the mitochondria, CoA availability, or mitochondrial enzyme function is impaired.
Adipic acid (C6 dicarboxylic acid) and suberic acid (C8) elevation together suggest medium-chain acyl-CoA dehydrogenase (MCAD) insufficiency or cofactor depletion — riboflavin is required for medium-chain acyl-CoA dehydrogenase function via FAD. One of the more actionable OAT findings, because riboflavin repletion often produces rapid improvement in fatigue and energy in people with this pattern.
3-Hydroxy acids (3-hydroxybutyric acid, 3-hydroxydicarboxylic acids) in the context of non-fasted urine may indicate impaired L-carnitine transport of long-chain fatty acids into mitochondria, impaired long-chain dehydrogenase activity (which requires riboflavin), or simple carnitine deficiency. L-carnitine is synthesized endogenously from lysine and methionine with assistance from vitamin C, but its synthesis can fall short under high metabolic demand, a vegetarian diet (carnitine is found primarily in red meat), or impaired methylation required for trimethyllysine synthesis.
Elevated 3-hydroxy acids with low-normal or normal conventional carnitine levels can indicate marginal functional carnitine insufficiency that standard testing doesn’t catch.
B Vitamin Functional Markers: What the Acids Reveal
Methylmalonic acid (MMA) is the marker most specifically elevated in functional B12 (cobalamin) deficiency. The enzyme methylmalonyl-CoA mutase requires adenosylcobalamin (one of the two active forms of B12) to convert methylmalonyl-CoA to succinyl-CoA — a step connecting odd-chain fatty acid and amino acid metabolism to the Krebs cycle. When B12 is functionally insufficient, MMA accumulates and appears in urine.
Importantly, urine MMA elevates earlier in B12 deficiency than serum B12 drops — it detects functional deficiency before serum levels turn abnormal. An elevated urine MMA with normal serum B12 is a frequent finding in functional medicine practice and supports B12 supplementation even when conventional blood testing would suggest adequacy.
Xanthurenate and kynurenate elevations indicate functional B6 (pyridoxine) deficiency. These compounds are byproducts of the kynurenine pathway of tryptophan metabolism, produced when the B6-dependent enzyme kynureninase can’t efficiently convert kynurenine to alanine. When B6 is insufficient, kynurenine gets shunted to xanthurenate and kynurenate instead. This is the same pathway that, when over-activated by inflammation, produces quinolinic acid — the neurotoxic metabolite — and depletes serotonin by stealing tryptophan away from the serotonin synthesis pathway.
B6 insufficiency therefore simultaneously creates functional kynurenine pathway derangement and may reduce serotonin and melatonin synthesis from tryptophan.
Formiminoglutamic acid (FIGLU) elevation indicates functional folate deficiency. FIGLU is an intermediate in histidine catabolism, converted to glutamic acid by a folate-dependent enzyme. When folate is insufficient, FIGLU accumulates. Particularly relevant for patients with MTHFR variants, who may maintain adequate total folate status while having inadequate active (5-MTHF) folate for specific enzymatic reactions including FIGLU catabolism. Elevated FIGLU with normal serum folate is a functional deficiency pattern that responds to methylfolate supplementation.
Pantothenate (B5) deficiency shows up as impaired CoA synthesis, which affects virtually every step of the Krebs cycle and fatty acid metabolism. Direct markers of B5 deficiency aren’t standard OAT findings in most panels, but the pattern of multiple Krebs cycle disruptions without clear single enzyme involvement may prompt B5 evaluation.
Riboflavin (B2) deficiency, as noted, affects multiple FAD-dependent dehydrogenases including the Krebs cycle Complex II and fatty acid beta-oxidation enzymes — its deficiency creates multiple concurrent OAT abnormalities that can initially look confusing until the common thread is identified.
Neurotransmitter Metabolites
The OAT includes metabolites that reflect neurotransmitter synthesis and metabolism, providing a window into serotonin, dopamine, catecholamine, and GABA metabolism unavailable through other standard testing.
5-Hydroxyindoleacetic acid (5-HIAA) is the primary metabolite of serotonin. Elevated 5-HIAA may indicate increased serotonin synthesis and turnover (which can signal serotonin excess, relevant in serotonin syndrome diagnosis, or simply high tryptophan availability and adequate synthesis pathway function). Very elevated 5-HIAA can indicate a neuroendocrine tumor (carcinoid) secreting excess serotonin — a finding that mandates urgent medical evaluation.
Low 5-HIAA suggests reduced serotonin synthesis or turnover, which may reflect inadequate tryptophan availability (common when the kynurenine pathway is overactivated by inflammation), inadequate cofactors for serotonin synthesis (B6, iron, folate), or low tryptophan dietary intake.
Homovanillic acid (HVA) and vanillylmandelic acid (VMA) are metabolites of dopamine and norepinephrine/epinephrine respectively. Their ratio and absolute levels provide information about catecholamine synthesis and metabolism. Low HVA may indicate reduced dopamine synthesis (relevant to motivation, reward, attention, and movement) and can appear in chronic stress that depletes catecholamine precursors.
Elevated VMA relative to HVA may indicate increased norepinephrine/epinephrine synthesis and breakdown — a pattern consistent with chronic stress response or HPA axis hyperactivation.
Kynurenic acid and quinolinic acid — the “kynurenine metabolites” — are among the most clinically significant OAT findings, particularly for neurological and psychiatric symptoms. As covered above, the kynurenine pathway gets activated by inflammation, stress, and infection, diverting tryptophan away from serotonin synthesis. Quinolinic acid is an NMDA receptor agonist and neurotoxin that in high amounts drives neuroinflammation, impairs hippocampal function, and contributes to cognitive dysfunction and depression.
Kynurenic acid, by contrast, is an NMDA receptor antagonist with neuroprotective properties — but in excess (driven by high inflammation) can impair glutamatergic neurotransmission. The kynurenate-to-quinolinate ratio indicates whether the kynurenine pathway is producing more neuroprotective or more neurotoxic metabolites, and is an actionable guide to anti-inflammatory interventions.
Microbial Markers: What the Gut Is Producing
Several OAT markers reflect gut microbial activity rather than human metabolism — specifically, the fermentation and metabolic products of gut bacteria and yeast that get absorbed from the gut and excreted in urine. This section offers indirect insight into gut dysbiosis that complements (and sometimes replaces) direct stool testing.
Arabinose is one of the most commonly elevated markers associated with Candida and yeast overgrowth. It’s produced as a fermentation byproduct of Candida species and certain other yeasts. Consistently elevated arabinose in OAT correlates with gut yeast overgrowth in clinical practice and often normalizes following antifungal treatment.
The correlation isn’t perfect — other bacteria can produce arabinose-related compounds, and high dietary intake of arabinose-containing foods can affect levels — but arabinose is among the better-validated OAT markers for yeast overgrowth.
Tartaric acid, citramalic acid, and 5-hydroxymethyl-2-furoic acid are additional yeast-associated markers. Tartaric acid matters in particular — it inhibits malic dehydrogenase (a Krebs cycle enzyme), providing a mechanism by which yeast overgrowth directly impairs mitochondrial energy production beyond simple competition for nutrients. Elevated tartaric acid therefore creates a double problem: it indicates gut yeast overgrowth and simultaneously impairs Krebs cycle function.
DHPPA (3,4-dihydroxyphenylpropionic acid) and HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) are bacterial metabolites associated with Clostridia species in the gut. Clostridium species produce phenolic compounds through aromatic amino acid metabolism, and their elevated levels reflect Clostridia overgrowth. HPHPA, specifically, is a dopamine beta-hydroxylase inhibitor — it inhibits the enzyme that converts dopamine to norepinephrine. Clinically, Clostridia overgrowth with elevated HPHPA has been associated with autism spectrum disorder symptoms (though causality isn’t established), ADHD, and mood disorders, possibly through this dopamine-to-norepinephrine conversion impairment.
Oxalic acid (oxalate) elevation is one of the more clinically significant OAT findings. Oxalate in the body comes from three sources: endogenous production from glycine and hydroxyproline metabolism, dietary absorption (spinach, nuts, chocolate, tea are high-oxalate foods), and production by gut Aspergillus and Candida species (which produce oxalic acid as a metabolic byproduct). High urinary oxalate is the primary risk factor for calcium oxalate kidney stones, the most common kidney stone type.
But oxalate’s clinical effects extend beyond kidney stones — oxalate crystal deposition in tissues including joints, connective tissue, thyroid, and the nervous system has been documented in patients with hyperoxaluria, potentially driving pain, thyroid dysfunction, and neurological symptoms.
Oxidative Stress Markers
8-Hydroxy-2-deoxyguanosine (8-OHdG) is a product of oxidative DNA damage. When ROS attack DNA, they produce 8-OHdG at guanine residues. Elevated urinary 8-OHdG indicates ongoing oxidative DNA damage and is a recognized biomarker of mitochondrial oxidative stress. Elevated in ME/CFS, diabetes, cancer, cardiovascular disease, and chronic inflammation. Elevated 8-OHdG points toward the need for antioxidant support: NAC, CoQ10, vitamin C, vitamin E, lipoic acid, and reduction of prooxidant exposures.
Pyrroles (hydroxyhemopyrrolin-2-one, HPL) elevation — sometimes called pyroluria or kryptopyrroluria — is a controversial OAT finding. Pyrroles form during hemoglobin synthesis and bind zinc and B6, complexing them for urinary excretion. The theory: excessive pyrrole production depletes zinc and B6, producing combined zinc-B6 deficiency with characteristic symptoms including poor stress tolerance, poor dream recall, white spots on nails, and sensory sensitivities.
The pyroluria concept has adherents in functional medicine but limited conventional acceptance, since the methodology for pyrrole testing has been criticized and strong clinical trials are absent. That said, the pattern of B6 and zinc deficiency is clinically real regardless of the mechanism, and functional B6 deficiency markers (elevated kynurenate and xanthurenate on OAT) combined with low zinc on micronutrient testing provide more validated support for B6-zinc support than pyrrole measurement alone.
Putting It Together: A Clinical Case Example
The art of OAT interpretation is pattern recognition across the full panel — not treating each elevated marker as an isolated finding. Consider the following pattern, not uncommon in chronic fatigue presentations:
Elevated pyruvate and lactate (impaired pyruvate entry into Krebs cycle) → points toward PDC dysfunction → thiamine and lipoic acid insufficiency. Elevated succinic acid with low fumarate and malate (Complex II region dysfunction) → points toward riboflavin insufficiency. Elevated suberic and adipic acids (fatty acid beta-oxidation impairment) → points toward carnitine insufficiency and riboflavin deficiency (consistent with the succinic acid finding). Elevated xanthurenate (B6 functional deficiency). Elevated MMA (B12 functional deficiency). Elevated arabinose (gut yeast overgrowth).
Elevated quinolinic acid (neuroinflammation driving the kynurenine pathway toward neurotoxic products).
This isn’t nine separate problems. It’s one coherent metabolic picture: multiple B vitamin functional deficiencies creating impaired mitochondrial energy production, concurrent gut dysbiosis, and neuroinflammation driving neurotransmitter imbalance. The intervention approach addresses the B vitamin pattern (thiamine as benfotiamine, riboflavin, methylcobalamin, P5P form of B6), supports mitochondrial function directly (CoQ10, carnitine, lipoic acid), addresses gut yeast (antifungal protocol), and targets neuroinflammation (anti-inflammatory dietary changes, omega-3s, NAC).
Patricia’s OAT told exactly this story. At six months of systematic intervention targeting the identified deficiencies, her follow-up OAT showed normalization of most markers, and her symptom burden had reduced by roughly 65 percent. Not “cured” — chronic illness rarely works that cleanly. But she had a mechanistic explanation, an actionable treatment protocol, and objective evidence of improvement.
After four years of being told her problem was psychological, the organic acids test had provided both the map and the compass.
Common Questions About Organic Acids Testing
How do I collect urine for an organic acids test?
Most OAT protocols require a first morning urine sample, collected after at least eight hours of overnight fasting. This matters because fasting ensures organic acid patterns reflect endogenous metabolism rather than recent dietary intake. Some markers — particularly those reflecting fatty acid oxidation — show more clearly abnormal in the fasted state. The sample gets frozen immediately or refrigerated and shipped with ice packs per the specific laboratory’s instructions.
Probiotics should be paused for at least two to three days before collection, since live bacteria produce organic acids that affect the microbial markers section. Some testing protocols specify avoiding certain high-oxalate or high-phenol foods for two to three days before collection.
How reliable is the organic acids test, and what are its limitations?
The analytical reliability of GC-MS and LC-MS/MS is excellent — the technology is highly precise and accurate. The interpretive reliability — whether elevated or depleted markers mean what functional medicine practitioners claim — is more variable and generally less validated through large clinical trials than conventional tests. The Krebs cycle and mitochondrial markers have strong biochemical support for their interpretations. The neurotransmitter metabolites and vitamin functional markers have reasonable support.
The microbial markers (arabinose for Candida, HPHPA for Clostridia) have clinical use but aren’t as rigorously validated as stool-based testing for the same organisms. Reference ranges derive from relatively small reference populations and vary between laboratories. The test is a tool for generating hypotheses and prioritizing interventions, not a definitive diagnostic oracle — clinical correlation is always required.
Can children have OAT testing, and are the markers the same?
Yes, and OAT is frequently used in pediatric functional medicine practice, particularly for children with autism spectrum disorder, ADHD, and chronic health issues. Reference ranges differ significantly by age — particularly in the first several years of life, when metabolic patterns are developmentally distinct. Some markers abnormal in adults are normal in young children and vice versa. Laboratory reports include age-appropriate reference ranges, and interpretation should come from a practitioner familiar with pediatric metabolic patterns.
The microbial markers — particularly Clostridia markers (HPHPA) and yeast markers (arabinose) — have been studied in autism research with some consistent findings, though interpretation and treatment implications continue to be refined in the literature.
How often should OAT be repeated?
For patients actively implementing interventions based on OAT findings, retesting at four to six months provides useful information about treatment response and whether the targeted deficiencies have normalized. For stable patients using OAT as part of wellness monitoring, annual testing is commonly used to track metabolic patterns over time. Some practitioners run baseline testing, retest after three months of intervention, then transition to annual monitoring.
The cost (typically $250 to $500 depending on the panel and laboratory) is a practical consideration — repeat testing should happen when it’ll change management decisions, not reflexively.
What is the difference between OAT and standard metabolic panels?
Standard metabolic panels (CMP, BMP) measure electrolytes, kidney function markers, liver enzymes, and blood glucose — organ function markers that detect disease once organs are significantly impaired. They don’t measure metabolic pathway efficiency, cofactor sufficiency, or microbiome metabolic activity.
Organic acids testing provides information standard panels completely miss, and it’s only abnormal when the metabolic dysfunction is at an early or subclinical stage — precisely the stage where intervention can prevent the disease progression that would eventually show up on standard panels. The two types of testing complement rather than duplicate each other: standard panels assess organ health, OAT assesses metabolic function.
The Amino Acid Metabolites Section
Methylcitric acid elevation is a marker of propionic acid accumulation. Propionic acid is produced from odd-chain fatty acid catabolism and from threonine and methionine breakdown. It’s also produced in large amounts by certain gut bacteria — particularly Clostridia and Bacteroidetes species — through fermentation of dietary fiber. Excess propionate inhibits succinate dehydrogenase (the Krebs cycle enzyme at Complex II), impairs PDC activity, and increases ammonia production.
In the context of severe gut dysbiosis with Clostridia overgrowth, propionate overproduction can drive neurological symptoms including cognitive dysfunction and behavioral changes through direct mitochondrial and neurotransmitter interference. Methylcitric acid on OAT is therefore both a marker of propionate accumulation and an indirect indicator of certain types of gut dysbiosis.
Homogentisic acid and succinylacetone elevations indicate impaired phenylalanine and tyrosine catabolism, respectively. These findings can point to genetic enzyme deficiencies (alcaptonuria, tyrosinemia) at very high levels, or simply to functional insufficiency of the relevant enzymes at lower elevations. Tyrosine is the precursor to dopamine, norepinephrine, epinephrine, and thyroid hormones — impaired tyrosine metabolism affects all of these synthesis pathways at once.
Phenylacetic acid and phenylpropionic acid (when elevated) suggest bacterial metabolism of phenylalanine in the gut — a byproduct of certain anaerobic bacterial species that can be absorbed and affect the central nervous system through the gut-brain axis. The phenolic compounds gut bacteria produce from aromatic amino acids are believed to affect neurotransmitter synthesis and blood-brain barrier integrity, providing another mechanistic connection between gut dysbiosis and neurological symptoms.
The glutaric acid and methylsuccinic acid markers round out the amino acid catabolism section. Glutaric acid elevation indicates impaired glutaryl-CoA dehydrogenase activity — an enzyme in lysine and tryptophan catabolism that requires riboflavin. Elevated glutaric acid alongside other riboflavin-dependent enzyme elevations strengthens the case for functional riboflavin insufficiency.
Isolated glutaric acidemia can also indicate the genetic disorder glutaric acidemia type I, which causes progressive neurological damage without adequate management — the OAT finding should prompt clinical evaluation for this diagnosis when levels run markedly elevated without other cofactor deficiency context.
Detoxification and Methylation Markers
Several OAT markers reflect the efficiency of detoxification pathways and the methylation cycle — both critical for neurological health, immune function, and processing environmental toxins, hormones, and metabolic waste products.
Glucaric acid in urine is a marker of glucuronidation — phase II liver detoxification that converts fat-soluble toxins, hormones, and drugs into water-soluble glucuronide conjugates for urinary excretion. Elevated glucaric acid indicates upregulated glucuronidation, typically a sign of increased detoxification load — environmental toxin exposure, high estrogen, drug metabolism, or significant oxidative stress.
It should prompt consideration of reducing toxic exposures and supporting phase II detoxification with cruciferous vegetables (which upregulate glucuronosyltransferases), calcium D-glucarate, and other liver support nutrients.
Sulfate and sulfite markers reflect the sulfation pathway — another phase II detoxification route critical for estrogen metabolism, neurotransmitter inactivation, and environmental toxin processing. Low sulfate with elevated sulfite may indicate impaired sulfite oxidase activity, which requires molybdenum as a cofactor. A relatively uncommon finding, but one that produces characteristic sensitivity to sulfite-containing foods and wine and may contribute to sulfur-containing supplement intolerance.
The OAT markers of methylation function — particularly related to the methionine cycle and SAM-e production — complement genetic methylation testing (MTHFR, COMT, MTRR variants) by showing the functional consequences of those genetic variants. Elevated homocysteine (when included in extended panels) indicates methylation cycle impairment. The combination of OAT functional markers and genetic methylation panel provides the most complete picture of methylation status, guiding decisions about methylfolate, methylcobalamin, and SAM-e supplementation with appropriate precision.
Understanding OAT results requires a practitioner who understands these pathways not as isolated boxes but as an interconnected metabolic web.
The test’s full value is only realized when interpretation moves beyond “this is elevated, therefore supplement this” to “this pattern of elevations and depletions indicates this specific metabolic dysfunction, best addressed through these targeted interventions.” Patricia’s experience — nine doctors, four years, no answers, then a single comprehensive metabolic test that revealed the entire picture — isn’t an indictment of medicine so much as a demonstration of what happens when the right questions never get asked.
The organic acids test asks many of the right questions simultaneously. The answers, interpreted skillfully, can change the trajectory of chronic illness in ways conventional testing simply cannot.
Mitochondrial Function Markers: Beyond the Krebs Cycle
Mitochondrial function involves more than the Krebs cycle and electron transport chain. The OAT provides several markers reflecting other aspects of mitochondrial health, including energy transport, cofactor status within the mitochondria, and mitochondrial membrane integrity.
Hydroxymethylglutaric acid (HMG) elevation has two very different interpretations depending on its magnitude. Moderately elevated HMG can indicate impaired HMG-CoA lyase activity in the ketone body synthesis pathway, or it can reflect HMG-CoA reductase activity — the same enzyme statins inhibit to lower cholesterol. In patients taking statins, HMG may be elevated as a direct consequence of drug mechanism. At very high levels, HMG aciduria indicates a rare organic acidemia.
The clinical context — statin use, ketogenic diet, symptoms — guides interpretation of HMG findings.
Beta-hydroxybutyrate and acetoacetic acid levels reflect ketone body production and utilization. In non-fasted individuals on standard diets, elevated ketones suggest impaired glucose utilization forcing greater reliance on fat oxidation and ketogenesis. This pattern shows up in early insulin resistance, in mitochondrial dysfunction that impairs glucose entry into the Krebs cycle (pyruvate dehydrogenase impairment), and in various metabolic disorders.
Alongside other mitochondrial markers, elevated ketones with elevated pyruvate strongly suggests PDC dysfunction directing the metabolic system toward fat-based rather than glucose-based fuel.
N-acetylcysteine (NAC) and related sulfur amino acid markers, when included in expanded panels, reflect glutathione precursor availability. Glutathione is the master antioxidant of the mitochondrion, protecting the electron transport chain complexes from oxidative damage.
Consistently low cysteine availability — whether from dietary protein insufficiency, impaired transsulfuration pathway (converting homocysteine to cysteine, which requires B6 and B12), or excessive oxidative demand consuming cysteine faster than it’s supplied — reduces mitochondrial glutathione, increasing vulnerability of the electron transport chain to oxidative damage. This creates a vicious cycle: mitochondrial dysfunction increases ROS, ROS damage mitochondrial components including the complexes, damaged complexes produce more ROS, and all of it consumes more glutathione.
Supplemental NAC breaks this cycle by providing the rate-limiting substrate for glutathione synthesis.
Carnitine-related markers in OAT reflect the availability and utilization of this essential transport molecule. Normal intracellular carnitine is required for long-chain fatty acid entry into the mitochondrial matrix, for export of toxic acyl groups from the mitochondria (preventing acyl-CoA accumulation that inhibits enzyme function), and for the malate-aspartate shuttle via acetylcarnitine transport. The OAT doesn’t measure carnitine directly, but the dicarboxylic acid accumulation pattern described earlier indirectly reflects carnitine status.
Direct plasma free carnitine and acylcarnitine profiling from a blood sample provides more specific carnitine information, and many practitioners order both OAT and plasma carnitine when the OAT suggests fatty acid oxidation impairment.
The convergence of multiple mitochondrial markers — Krebs cycle intermediates, fatty acid oxidation markers, electron transport chain cofactor indicators, oxidative stress markers — into a coherent pattern of mitochondrial dysfunction is the most powerful finding the OAT can provide.
For patients with unexplained chronic fatigue, cognitive dysfunction, exercise intolerance, and the characteristic symptom profile of ME/CFS or Long COVID, this pattern — when present — offers both validation that the symptoms have a biological basis and a roadmap for targeted intervention that goes far beyond generic “take more vitamins” advice. The test doesn’t diagnose a disease. It illuminates the functional terrain of the metabolic system and points toward where the roads are blocked.
Navigation from that point is clinical work. But you can’t work through without a map.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map